3163 Reducing the anticholinergic burden of patients in the inpatient and outpatient setting

Abstract Introduction Anticholinergic medications are associated with cognitive decline and increased risk of falls. This link is dose dependent and has been shown to decrease with medication discontinuation, therefore reducing the anticholinergic burden of patients represents an opportunity to prevent patient harm and improve quality of life. This project aims to improve patients’ anticholinergic burden (ACB) scores following admission to Meadowlands Care of the Elderly Unit and presentation to the Frailty Assessment Unit. Methods We began by conducting two simultaneous audits in the inpatient and outpatient setting. We audited ACB scores on presentation and on discharge from the inpatient ward or following clinic review as appropriate. We then completed two PDSA cycles. Our first intervention involved a teaching session for doctors on the risks associated with anticholinergic medication and the benefits of reducing ACB scores. Our second intervention was a poster directing staff to the ACB calculator and raising awareness of the risks of anticholinergic medications for our patients. Results In both the inpatient and outpatient setting, and regardless of intervention, the average ACB score improved following admission or outpatient review. In the inpatient setting the average reduction was 0.57, and in the outpatient setting the average reduction was 0.35. However, there was no clear improvement in the reduction of ACB scores associated with any of our interventions. Conclusion While it was encouraging to see that following admission under the Care of the Elderly Team or after review at the Frailty Assessment Unit there was a reduction in patients’ anticholinergic burden, this reduction is small and could potentially be improved. Unfortunately, our interventions did not bring about this improvement. There are multiple possible reasons for this, including the rotational nature of trainee medical staff and the lack of pharmacist involvement.

Authors

Publication Details

Journal
Age and Ageing
Published
2025-07-01
DOI
https://doi.org/10.1093/ageing/afaf133.056
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

3163 Reducing the anticholinergic burden of patients in the inpatient and outpatient setting

Peter D. Rogan, C Gribbon
Age and Ageing
Pharmaceutical Practices and Patient Outcomes
article

3163 Reducing the anticholinergic burden of patients in the inpatient and outpatient setting

Peter D. Rogan, C Gribbon
article en

Abstract

Abstract Introduction Anticholinergic medications are associated with cognitive decline and increased risk of falls. This link is dose dependent and has been shown to decrease with medication discontinuation, therefore reducing the anticholinergic burden of patients represents an opportunity to prevent patient harm and improve quality of life. This project aims to improve patients’ anticholinergic burden (ACB) scores following admission to Meadowlands Care of the Elderly Unit and presentation to the Frailty Assessment Unit. Methods We began by conducting two simultaneous audits in the inpatient and outpatient setting. We audited ACB scores on presentation and on discharge from the inpatient ward or following clinic review as appropriate. We then completed two PDSA cycles. Our first intervention involved a teaching session for doctors on the risks associated with anticholinergic medication and the benefits of reducing ACB scores. Our second intervention was a poster directing staff to the ACB calculator and raising awareness of the risks of anticholinergic medications for our patients. Results In both the inpatient and outpatient setting, and regardless of intervention, the average ACB score improved following admission or outpatient review. In the inpatient setting the average reduction was 0.57, and in the outpatient setting the average reduction was 0.35. However, there was no clear improvement in the reduction of ACB scores associated with any of our interventions. Conclusion While it was encouraging to see that following admission under the Care of the Elderly Team or after review at the Frailty Assessment Unit there was a reduction in patients’ anticholinergic burden, this reduction is small and could potentially be improved. Unfortunately, our interventions did not bring about this improvement. There are multiple possible reasons for this, including the rotational nature of trainee medical staff and the lack of pharmacist involvement.

Age and AgeingVol. 54(Supplement_2)
Openalex Percentile: Top 81%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

3163 Reducing the anticholinergic burden of patients in the inpatient and outpatient setting — Peter D. Rogan, C Gribbon · Age and Ageing (2025) | TGRS Research Map | TGRS